about
Long-QT syndrome: from genetics to managementManagement of Patients with Long QT SyndromeA 26-year-old woman with recurrent loss of consciousness.Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy.Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient managementRisk stratification in young patients with channelopathies.Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndromePharmacological and non-pharmacological management of the congenital long QT syndrome: the rationaleCombined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndromeIdentification of a novel KCNQ1 mutation in a large Saudi family with long QT syndrome: clinical consequences and preventive implications.Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.Genotype-specific risk stratification and management of patients with long QT syndrome.Novel calmodulin mutations associated with congenital arrhythmia susceptibility.Genetics of long QT syndrome.A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers.Inpatient detection of cardiac-inherited disease: the impact of improving family history takingClinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter StudyImplantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.Impact of genetics on the clinical management of channelopathies.ß-adrenoceptor blockers increase cardiac sympathetic innervation by inhibiting autoreceptor suppression of axon growthNot all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprololA KCNE1 missense variant (V47I) causing exercise-induced long QT syndrome (Romano Ward).Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervalsSports Participation in Genotype Positive Children With Long QT Syndrome.Cardiovascular health, part 2: sports participation in athletes with cardiovascular conditions.Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statisticsIdentification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndromePropranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patientsPrevalence of the congenital long-QT syndrome.Genotype- and phenotype-guided management of congenital long QT syndrome.Use of implantable cardioverter-defibrillators.Congenital long and short QT syndromes.The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy.Genetics of sudden cardiac death caused by ventricular arrhythmias.Personalized medicine to treat arrhythmias.Implantable cardioverter-defibrillators in children.Must every child with long QT syndrome take a beta blocker?Congenital long QT syndromes: prevalence, pathophysiology and management.Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
P2860
Q26823298-65646FC8-8AFB-482F-A38D-529C582DA90AQ28070269-871E2342-822B-437A-A240-376DD48AD874Q30460335-F9C2A807-A8FB-42C0-8806-0E48C84DA838Q33157716-C9890439-47A8-427F-ACBC-D888776726D3Q33158481-DDC02309-5E54-4ABD-A921-65CD7CD7A878Q33158864-32B1A5A2-D643-415D-93AB-3EA588EE18A2Q33159731-7612D12A-93E9-4FAE-B331-21E755868F19Q33159820-C9B6C1FC-F68A-4F9A-AE3F-C1E546F84D7BQ33160912-41113715-569C-4267-8ACF-6F35FA1110F7Q33161423-D4FE2BA4-374D-43EC-B47C-8C9DF090DCEFQ33163183-E55AA1DC-DDC9-4607-AEE0-0F5F1929B99CQ33163507-B835C1AE-FD72-49D6-A5D8-9BA361717366Q33164413-72B316D7-BD46-4B85-BB86-C687DCB67AFFQ33164422-E3A3B7EF-A3E8-4D82-AB7D-3DE15072CA42Q33164518-AE703489-8DA5-4115-9B32-D4B6A969EC4CQ33166859-EDC24626-9A99-44F9-BDE9-76D00500AA0DQ33167640-46B305AB-E4C3-45EC-9390-1DF5568F09D7Q33167993-3C5A8647-6624-43ED-8AC0-909EA8966550Q34036797-AC472A4F-1DF7-4EF1-827F-251BEC137B90Q34186735-D7379CCF-93B0-449F-859F-614137331AF3Q34307224-07EBB7E5-61AA-4094-ADF8-04F5952296A1Q35659392-BBE8FC9C-B66D-4A29-A212-F1372F4B478AQ35904744-9A2AF14A-3C54-4035-AE2A-6E7EB739E635Q35966848-8420A09C-3368-44D6-9D9E-B0BD376EC3C3Q36225404-C7521A31-1180-4677-8308-8617FD55CC10Q36537110-8FB571B3-470C-4B86-843C-4A7D272F64F7Q37380061-2B46BA19-498E-47AC-8C1F-1CF29FD2FF4CQ37396467-41CDF666-EDCF-4172-9A07-627E75186C12Q37440443-178B9224-D076-48A0-B430-4BDF1217CC31Q37442080-C53055E6-8272-48A6-99C6-86D7F2ED3323Q37613089-1764B226-9EAB-4151-9F60-E54172AC443BQ37818218-EC4B9455-5074-47D9-8DEF-1C5294F41284Q38036038-07693088-5BB3-4747-929D-9A0FA35691DEQ38091053-74EE6E1A-55F8-4929-B72F-C06145BD7244Q38169914-A9737019-6154-4E11-A641-90454210FD6AQ38203726-FD5C8099-5F0B-4F17-BC7E-E1E96DF3380DQ38253613-BB61BABA-8352-48A6-8ECD-E1957AEDDE04Q38255700-D1B15718-E64E-44F4-B480-112660A4C28FQ38257479-FC5CE7B0-A399-44CD-95D9-85BE5D6EFA6AQ38321098-F8400FDC-52BF-4DC5-8FE0-1E0944881935
P2860
description
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2009
@uk
name
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@en
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@nl
type
label
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@en
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@nl
prefLabel
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@en
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@nl
P2093
P50
P1433
P1476
High Efficacy of β-Blockers in Long-QT Syndrome Type 1
@en
P2093
Candice Bithell
Carla Spazzolini
Elizabeth Villain
G. Michael Vincent
Heikki Swan
Isabelle Denjoy
Jean-Marc Lupoglazoff
Kirsi Piippo
Silvia G. Priori
P304
P356
10.1161/CIRCULATIONAHA.108.772533
P407
P577
2009-01-20T00:00:00Z